P272Genetic aspects of thrombus formation in left atrial appendage in patients with atrial fibrillation

    loading  Checking for direct PDF access through Ovid



To study the role of genetic polymorphisms of cytochrome P450 2C9 (CYP2C9), vitamin K epoxide reductase complex subunit 1 (VKORC1) and plasminogen activator inhibitor -1 (PAI-1) in left atrial appendage (LAA) thrombus formation in patients with atrial fibrillation.


Studied were 100 patients with coronary heart disease and permanent atrial fibrillation, mean age was 65.4 ± 5.4 years. Patients were divided into two groups according to results of transesophageal echocardiography: group 1 included 50 patients with LAA thrombosis, group 2 — 50 patients without LAA thrombosis who were age and sex matched. We evaluated genetic polymorphisms Arg144Cys and Ile359Leu of CYP2C9, C1173T and G3730A of VKORC1 and -675 5G/4G of PAI-1.


The frequency of CC, CT and TT genotypes of VKORC1 C1173T among all the patients was 28%, 54% and 18%, GG, GA and AA genotypes of VKORC1 G3730A — 38%, 52% and 10%, 5G/5G, 5G/4G and 4G/4G genotypes of PAI-1 -675 5G/4G — 42%, 48% and 10% respectively. The frequency of CYP2C9*1/*1, *1/*2 and *1/*3 genotypes was 69%, 18% and 13% respectively. In our study, no genotypes CYP2C9*2/*2 and CYP2C9*3/3 were observed. Genotypes distribution fulfilled expectations of Hardy-Weinberg equilibrium.


Patients of the 1 group had 4G allele of PAI-1 -675 5G/4G 10% more frequently (p=0.005) and genotype CC of VKORC1 C1173T 35% more frequently (p=0.01) than patients of the 2 group. Correlations between CC genotype of VKORC1 C1173T and LAA thrombosis (r=0.46; p=0.01) and between 4G allele of PAI-1 -675 5G/4G and LAA thrombosis (r=0.35; p=0.01) were observed. The odds ratio for LAA thrombosis in patients with CC genotype of VKORC1 C1173T was 3.2 (95% CI 1.1 to 7.8) (p=0.02) and in patients with 4G allele of PAI-1 -675 5G/4G - 4.2 (95% CI 1.5 to 8.6) (p=0.02).


CC genotype of VKORC1 C1173T and 4G allele of PAI-1 -675 5G/4G are associated with LAA thrombosis in patients with permanent atrial fibrillation.

Related Topics

    loading  Loading Related Articles